GIVE NEW LIFE
TO SKIN
TO SKIN
OUR FOUNDER
Over 50 Years of Surgical & Skin Research
A visionary in cellular renewal, Dr. Gregory Brown pioneered the bridge between bioactive science and anti-aging skincare. His legacy is defined by a series of historic milestones. He was the first to validate the critical role of Nobel Prize-winning Epidermal Growth Factor (EGF) in skin repair, with his groundbreaking findings published in The New England Journal of Medicine in 1989. Furthermore, he was the first to secure the U.S. anti-aging patent for EGF application in 1994.
Thirty years later, Dr. Brown continues to lead at the edge of innovation. In 2024, he unveiled RVGF Technology. This advanced evolution transforms RéVive's signature bio-peptides into three exclusive peptides designed to address aging concerns once thought only manageable through surgical intervention.
RESEARCH LEGACY
OUR INNOVATION
RéVive once again pioneers the application of Nobel Prize-inspired technology to the field of skincare.
Introducing RVGF, our proprietary precision technology that helps protect the stability and efficacy of our three exclusive peptides, while ensuring precise binding to key protein targets. With a highly efficient delivery system, our peptides are able to revitalize the skin from within.
We analyzed a vast database of 200,000 human proteins to pinpoint the exact markers of aging.
This allows us to bidirectionally screen and identify the most potent peptide chains, ensuring every drop is engineered for maximum efficacy.
Utilizing advanced pharmaceutical-grade stabilization, we link our peptide chains to safeguard their bio-activity.
This ensures that our high-performance ingredients remain as fresh and potent on your skin as they were the day they were formulated.
Our innovative 5.8-nm tetrahedral structure is specifically engineered to match the natural gaps between skin cells.
This precision allows the technology to bypass the surface barrier, delivering active ingredients exactly where they are needed most.
KEY INGREDIENTS
*All the above data are derived from authoritative testing by third-party institutions. Skin roughness and cell metabolism data were obtained from in vitro skin model tests, while skin luminosity data were obtained from clinical tests, all tested via FLI technique.
*All the above data are derived from clinical tests conducted by authoritative third-party institutions.
*All the above data are derived from clinical tests conducted by authoritative third-party institutions.